Clinical Feasibility of the Preoperative C-reactive Protein-albumin-lymphocyte Index to Predict Short- and Long-term Outcomes of Patients with Gastric Cancer
Overview
Authors
Affiliations
Background: Gastric cancer (GC) is a major leading cause of cancer-related death worldwide. Systemic inflammation and the nutrition-based score are feasible prognostic markers for malignancies. Emerging evidence has also revealed the C-reactive protein-albumin-lymphocyte (CALLY) index to be a prognostic marker for several cancer types. However, its clinical significance to predict surgical and oncologic outcomes of patients with GC remains unclear.
Methods: We assessed the preoperative CALLY index in 426 patients with GC who received gastrectomy.
Results: A low preoperative CALLY index was significantly correlated to all well-established clinicopathologic factors for disease development, including an advanced T stage, the presence of venous invasion, lymphatic vessel invasion, lymph node metastasis, distant metastasis, and an advanced TNM stage. A low preoperative CALLY index was also an independent prognostic factor for overall survival (hazard ratio [HR], 2.64; 95 % CI, 1.66-4.2; P < .0001) and disease-free survival (HR, 1.76; 95 % CI, 1.01-3.05; P = .045). In addition, a low preoperative CALLY index was an independent predictive factor for postoperative surgical site infection (odds ratio, 2.64; 95 % CI, 1.42-4.89; P = .002).
Conclusion: The preoperative CALLY index is valuable for perioperative and oncologic management of patients with GC.
Reply to "Disregarding C-reactive protein in an inflammation-based nomogram?".
Cao Y, Song M, Deng S, Cai K Int J Colorectal Dis. 2025; 40(1):59.
PMID: 40056165 PMC: 11890316. DOI: 10.1007/s00384-025-04847-4.
Ding Y, Liu Y, Yu J, Cai C, Fu L, Zhu J Int J Chron Obstruct Pulmon Dis. 2025; 20:159-169.
PMID: 39867991 PMC: 11766151. DOI: 10.2147/COPD.S485036.
Xi P, Huang G, Huang K, Qin D, Yao Z, Jiang L J Inflamm Res. 2025; 18():621-635.
PMID: 39835294 PMC: 11745071. DOI: 10.2147/JIR.S495815.
Zhu D, Lin Y, Yao Y, Qi X, Qian K, Lin L BMC Cancer. 2024; 24(1):1499.
PMID: 39639229 PMC: 11619214. DOI: 10.1186/s12885-024-13261-y.
Li J, Zhang S, Hu X, Huang T, Chen M Surg Today. 2024; .
PMID: 39158606 DOI: 10.1007/s00595-024-02921-y.